Accelerating Healthcare & Life Sciences Innovation
from Discovery to Deployment.​
A premier New York City platform for digital health, AI, medtech, diagnostics, biotech and life sciences innovators entering or scaling in the U.S. market.​
About HITLAB
An evidence-first launchpad, proven since 1998​
For 25+ years, HITLAB’s rigorous, independent research has made health technologies U.S.-ready.​
-
Evidence made U.S.- ready​
We prepare each innovation's clinical and economic evidence to stand up to the scrutiny of U.S. payers, providers and regulators.
-
Pathways that open doors​
HITLAB communications channels and networks unlock new business, alliances, venture capital and grant funding.​
-
Impact at national scale​
The mission: move breakthrough technologies into U.S. care to improve the lives of 350 million Americans.​
Two Decades of Independent Proof
650+ validation studies conducted over 20+ years, with no investment stake, from our New York City base — the credibility U.S. stakeholders trust.​
Navigating The US Market
From Evidence to Adoption
We help non-U.S. innovators decode the ecosystem, clear regulatory and reimbursement hurdles, and prove their
platform through real-world pilots.​
-
U.S. healthcare ecosystem​
Map the stakeholders, buyers and care settings that decide whether a technology is adopted.​
-
Reimbursement pathways​
Identify the coding, coverage and payment routes that make the economics work for U.S. payers.​
-
FDA & CMS strategy​
Navigate FDA and CMS regulatory pathways and align to the resources each milestone demands.​
-
Pilot site relationships​
Develop relationships with U.S. pilot sites and health systems ready to test and adopt.​
-
IRB & study execution​
Lead IRB protocol development, approval and pilot study execution with clinical-research rigor.​
-
Adoption & alignment​
Align to U.S. customer expectations and drive platform adoption across the health system.​
Why HealthTech Launchpad USA​
A focused commercialization engine for healthcare and life sciences innovators seeking U.S. traction.​
-
Launch faster​
Clarify product-market fit, commercialization strategy and early customer pathways.​
-
Validate smarter​
Design pilots, outcomes frameworks and evidence-generation plans for adoption.​
-
Scale strategically​
Connect to the right health systems, pharma, payers, employers, investors and technology partners.​
Position innovators at the center of one of the world’s most dynamic healthcare, life sciences, technology and investment ecosystems.​
Built for innovators across healthcare and life sciences​
A cohort experience designed for founders, researchers and growth-stage teams ready to move from promise to proof.​
-
Digital health startups​
Care delivery, access, engagement, remote care and population health,etc
-
AI + analytics companies​
Clinical, operational, workflow and data-driven solutions.​
-
MedTech + devices​
Connected devices, diagnostics, wearables and regulated products.​
-
Biotech + therapeutics​
R&D platforms, precision medicine and life sciences innovation.​
-
Academic spinouts​
Translational research teams moving toward commercialization.​
-
International companies​
Non-U.S. innovators seeking traction in the U.S. market.​
-
Health system teams​
Innovation groups looking to validate or partner around solutions.​
-
Growth Stage Ventures
Companies preparing for customers, investors or strategic partners.​
-
1. Commercialization Strategy
Market assessment, competitive positioning, business model and pricing/reimbursement guidance.​
-
2. Clinical Validation
Pilot design, research collaborations, outcomes measures and real-world evidence planning.​
-
3. Strategic Partnerships
Curated access to providers, pharma, payers, employers, technology and research partners.​
-
4. Investment Readiness
Pitch refinement, capital strategy, due diligence preparation and investor introductions.​
-
5. U.S. Market Entry
Stakeholder mapping, regulatory navigation, U.S. business strategy and partnership development.​
The outcome: a practical, partner-ready commercialization roadmap with evidence priorities and clear next steps.​
What Participants Receive
Hands-on support across the moments that matter​
Every company receives targeted guidance, curated introductions and market-facing assets.​
-
Strategy Sprint
Positioning, messaging, market segment prioritization and commercialization roadmap.​
-
Pilot + Evidence Design
Study questions, deployment model, outcomes framework and partner-ready pilot package.​
-
Mentor Office Hours
Clinicians, investors, life sciences executives, operators and commercialization experts.​
-
Partner Matchmaking
Curated introductions to health systems, pharma, payers, employers, tech and research partners.​
-
Pitch + Investor Prep
Pitch narrative, data room expectations, funding pathway and diligence readiness.​
-
Showcase Visibility
Cohort demo day, innovation showcase, executive roundtable access and market exposure.​
Validation
Clinical validation​ & evidence generation​
Healthcare adoption requires more than a compelling product. Participants learn how to generate credible proof, define outcomes and structure pilots for enterprise buyers and clinical partners.​
-
Pilot Design
Define setting, users, workflows and endpoints.​
-
Research Collaboration
Align stakeholders around study design and operational needs.​
-
Outcomes Measurement
Identify metrics that matter to clinical, economic and operational decision-makers.​
-
Real World Evidence
Convert deployments into partner-ready proof points.​
Ecosystem
HealthTech Launchpad USA connects participants to the stakeholders needed to commercialize, validate,fund and scale.​
-
Health Systems
-
Pharma + Life Sciences​
-
Payers + Employers​
-
Investors​
-
Technology Partners​
-
Academic + Research​
U.S. Market Entry
A soft landing for global health innovators​
For international companies, the program creates a practical path to U.S. stakeholders, pilots, partners and market learning.​
-
Map
U.S. buyer and stakeholder landscape​
-
Adapt
Go-to-market, messaging and validation priorities​
-
Connect
Curated introductions to partners and advisors​
-
Launch
Pilot, evidence and commercial next steps​
Program Outcomes
Participants leave with assets that move the business forward​
Clear, tangible outputs designed to support adoption, fundraising, partnerships and revenue growth.​
-
Commercialization Roadmap
A prioritized pathway for target markets, buyers and near-term execution.​
-
Partner Ready Story
Sharper narrative, value proposition and use- case framing for enterprise stakeholders.​
-
Pilot Packaging
A practical pilot concept with success metrics, deployment considerations and evidence goals.​
-
Curated Introductions
Meaningful connections to potential customers, strategic partners, advisors and investors.​
-
Investment Readiness
Improved pitch materials, diligence preparation and capital strategy.​
-
Market Visibility
Showcase exposure across healthcare, life sciences and innovation audiences.​
The goal: shorten the path from promising innovation to healthcare impact.​
Case Studies
Proven across the HITLAB network​
A snapshot of health innovators HITLAB has helped validate, credential and scale in the U.S. market.​

Smart biometric garments​ (Canada)​
Smart crutch rehabilitation​ (Ukraine)​
AI ECG heart monitoring​ (Czechia)​

AI clinical navigation​ (Israel)​

AR-guided telepresence​ (Canada)​

Affordable telemedicine​ (India)​
Digital engineering solutions​ (Germany)​

Healthcare AI and data solutions​ (India)​
Medication engagement​ (Israel)​
Join the Next Cohort
Transform innovation into healthcare impact
-
Apply
For founders, spinouts and growth-stage teams ready to accelerate.​
-
Partner
For health systems, pharma, payers, employers, investors and technology partners.​
-
Sponsor
For organizations seeking visibility with high- potential healthcare innovators.​
Plan Your Liftoff
Get in touch with us to begin your journey